Ten-year Follow-up of Laser in Situ Keratomileusis in Patients 8 to 15 Years Old

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00800774

Enrollment

Registered

2008-12-02

Start date

1998-01-31

Completion date

2008-09-30

Last updated

2009-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anisometropia

Keywords

LASIK, safety, efficacy, stability, high anisometropia, patients 8 to 15 years old, conventional treatments have failed

Brief summary

The purpose of this study is to determine the safety, efficacy, predictability, and stability of laser in situ keratomileusis (LASIK) to correct high anisometropia in patients 8 to 15 years old in whom conventional treatments have failed.

Detailed description

Nine eyes of nine patients (3 male and 6 female) with high anisometropia (\>3.50 D), were included in this study. Minimum follow-up was 10 years. All patients were treated with the Chiron Technolas 217 excimer laser.

Interventions

PROCEDURELASIK

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

8 Years to 15 Years

Healthy volunteers

Yes

Inclusion criteria

* High anisometropia (\>3.50 D) * Patients 8 to 15 years old * Conventional treatments have failed

Exclusion criteria

* Diabetes * Autoimmune diseases * Topographic abnormalities

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026